2L
TRIB

22NW LP’s Trinity Biotech TRIB Stock Holding History

22NW LP’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,358
Closed -$2.72M – 41
2019
Q1 		$2.72M Hold
6,358
– – 1.89% 21
2018
Q4 		$2.18M Hold
6,358
– – 1.36% 28
2018
Q3 		$3.81M Hold
6,358
– – 2.05% 20
2018
Q2 		$4.77M Buy
6,358
+76
+1% +$54.8K 2.48% 15
2018
Q1 		$4.85M Buy
6,282
+458
+8% +$375K 2.53% 13
2017
Q4 		$4.46M Hold
5,824
– – 2.19% 14
2017
Q3 		$4.9M Hold
5,824
– – 2.86% 7
2017
Q2 		$5.24M Hold
5,824
– – 2.96% 6
2017
Q1 		$5.21M Buy
5,824
+1,023
+21% +$960K 3.01% 5
2016
Q4 		$4.98M Buy
+4,801
New +$4.96M 2.99% 5

Other funds holding TRIB

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
ARM
Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

22NW LP's TRIB Position: Q2 2019 in Review

22NW LP sold out of Trinity Biotech (TRIB) in Q2 2019, closing a stake of 6,358 shares — an estimated $2.72M sold.

22NW LP first reported a position in TRIB in Q4 2016 and held it in 10 quarters. The position peaked at $5.24M in Q2 2017. 34 funds tracked by Wall St. Rank hold TRIB as of Q2 2019.

  • 22NW LP reported no remaining Trinity Biotech position as of Q2 2019 after selling out during the quarter.
  • 22NW LP sold 6,358 Trinity Biotech shares in Q2 2019, an estimated $2.72M.
  • 22NW LP first reported a position in Trinity Biotech in Q4 2016 and held it in 10 quarters.
  • 22NW LP's Trinity Biotech position peaked at $5.24M in Q2 2017.
  • 34 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2019.

Based on 22NW LP's 13F filing for Q2 2019, filed 14 Aug 2019.